Table 1.
Demographic and clinical data
| Variables | No DAC (n = 21) | DAC (n=43) | p |
|---|---|---|---|
| Age (years) |
50±10 |
62±10 |
< 0.0001 |
| Male gender |
42.9% |
69.8% |
0.0563 |
| BMI (kg/m2) |
28±6 |
28±5 |
0.7119 |
| Relevant LV dysfunction |
0% |
33% |
0.0854 |
| Hypertension |
23.5% |
62.8% |
0.1142 |
| Hypercholesterolemia |
14.7% |
34.9% |
0.4074 |
| β Blockers |
17.7% |
48.8% |
0.1785 |
| Ca channels blockers |
2.9% |
16.3% |
0.2546 |
| ACE inhibitor |
17.7% |
51.2% |
0.1114 |
| Statins | 11.8% | 23.3% | 1 |
BMI: Body mass índex; ACE: Angiotensin converting enzyme.